Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 2,206 | 2,315 | 0 | 1,924 | 1,904 |
| Cost of Goods | 1,095 | 1,079 | N/A | 1,045 | 1,139 |
| Gross Profit | 1,111 | 1,236 | N/A | 879 | 765 |
| Operating Expenses | -1,000 | 2,151 | 0 | 2,089 | -1,000 |
| Operating Income | -903 | -836 | N/A | -1,163 | -1,429 |
| Other Income | 903 | 20 | 0 | 34 | 1,429 |
| Pre-tax Income | 0 | -816 | 0 | -1,129 | 0 |
| Net Income Continuous | N/A | -816 | N/A | -1,129 | N/A |
| Net Income | $N/A | $-816 | $N/A | $-1,127 | $N/A |
| EPS Basic Total Ops | -0.10 | -0.10 | N/A | -0.20 | -0.20 |
| EPS Basic Continuous Ops | N/A | -0.12 | N/A | -0.17 | N/A |
| EPS Diluted Total Ops | -0.10 | -0.10 | N/A | -0.20 | -0.20 |
| EPS Diluted Continuous Ops | N/A | -0.12 | N/A | -0.17 | N/A |
| EBITDA(a) | $2,273 | $-836 | $N/A | $-1,042 | $1,970 |